2.6K
Articles
90.1K
Citations
3.2
avg. Impact Factor
132
h-index

Most Cited Articles of Department of Medical Oncology and Therapeutics Research in 2017

TitleJournalYearCitations
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic LeukemiaNew England Journal of Medicine2017978
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice GuidelineJournal of Clinical Oncology2017539
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell TransplantationNew England Journal of Medicine2017487
FDA-Approved Oligonucleotide Therapies in 2017Molecular Therapy2017418
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II TrialJournal of Clinical Oncology2017366
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized TrialsJAMA - Journal of the American Medical Association2017268
A review of family caregiving intervention trials in oncologyCa-A Cancer Journal for Clinicians2017125
A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancerNature Communications2017101
Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma PatientsClinical Cancer Research201798
Epigenetic Regulation: A New Frontier for Biomedical EngineersAnnual Review of Biomedical Engineering201797
Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204.Journal of Clinical Oncology201795
Phase I Trial of Intratumoral Injection of Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8 T-cell InfiltrationClinical Cancer Research201792
MET in Lung Cancer: Biomarker Selection Based on Scientific RationaleMolecular Cancer Therapeutics201792
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer riskNpj Breast Cancer201778
DEVELOPING AND ADVANCING NURSING CARE COMPETENCIES IN PALLIATIVE AND END-OF-LIFE CAREInnovation in Aging201778
NIMG-57. SURVIVAL ANALYSIS OF GLIOBLASTOMA (GBM) PATIENTS RECEIVING NEURAL STEM CELL (NSC)-MEDIATED TREATMENT USING T1-WEIGHTED DYNAMIC CONTRAST ENHANCED (DCE) MRINeuro-Oncology201778
A rising trend in the incidence of advanced gastric cancer in young Hispanic menGastric Cancer201760
Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicityCancer201760
Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical TrialJAMA Oncology201754
Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasiaOncogene201749
Prevalence and Predictors of Sperm Banking in Adolescents Newly Diagnosed With Cancer: Examination of Adolescent, Parent, and Provider Factors Influencing Fertility Preservation OutcomesJournal of Clinical Oncology201749
Global geriatric oncology: Achievements and challengesJournal of Geriatric Oncology201748
Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy (ACCL05C1): A Report From the Children's Oncology GroupJournal of Clinical Oncology201747
Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell GrowthMolecular Therapy - Nucleic Acids201746
ALK-positive Large B-cell Lymphoma: A Clinicopathologic Study of 26 Cases With Review of Additional 108 Cases in the LiteratureAmerican Journal of Surgical Pathology201746